Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot. - Archive ouverte HAL Access content directly
Journal Articles Drugs Year : 2007

Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.

Domains

Life Sciences [q-bio] Immunology

Philippe Saas  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00479713

Submitted on : Sunday, May 2, 2010-12:48:24 PM

Last modification on : Friday, January 14, 2022-3:08:17 AM

Not file

Dates and versions

inserm-00479713 , version 1 (02-05-2010)

Identifiers

  • HAL Id : inserm-00479713 , version 1
  • PUBMED : 17683176

Cite

Xavier B. Pivot. Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.. Drugs, 2007, 67 (12), pp.1800-1. ⟨inserm-00479713⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-FCOMTE
51 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More